Top

Familial Cancer

Published in:

01-06-2003

Familial melanoma: a complex disorder leading to controversy on DNA testing

Authors: Femke A. de Snoo, Wilma Bergman, Nelleke A. Gruis

Published in: Familial Cancer | Issue 2/2003

Title: Familial melanoma: a complex disorder leading to controversy on DNA testing
Authors: Femke A. de Snoo
Wilma Bergman
Nelleke A. Gruis
Publication date: 01-06-2003
Publisher: Kluwer Academic Publishers
Published in: Familial Cancer / Issue 2/2003
Print ISSN: 1389-9600
Electronic ISSN: 1573-7292
DOI: https://doi.org/10.1023/A:1025758527675

Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras

Prof. Fabrice Barlesi

Developed by: Springer Medicine

At a glance: The STEP trials

Springer Medicine

Please log in to get access to this content

Other articles of this Issue 2/2003

Genotype and phenotype of patients with both familial adenomatous polyposis and thyroid carcinoma

The information and support needs of women at high risk of familial breast and ovarian cancer: how can cancer genetic services give patients what they want?

Lack of association between early onset of breast cancer and numbers of affected relatives in an Iranian population

Abstracts presented at the XVIth symposium of The Netherlands Foundation for the Detection of Hereditary Tumours, 'New Developments in Hereditary Cancer', 31 January 2003, Utrecht, The Netherlands

Erratum

Bannayan–Riley–Ruvalcaba syndrome: further delineation of the phenotype and management of PTEN mutation-positive cases

Keynote webinar | Spotlight on antibody–drug conjugates in cancer